Literature DB >> 22844564

Increased incidence of endoscopic erosive esophagitis in solid organ transplant recipients.

In Soo Kim1, Hyuk Lee, Jun Chul Park, Sung Kwan Shin, Sang Kil Lee, Yong Chan Lee.   

Abstract

BACKGROUND/AIMS: Solid organ transplant recipients frequently report gastrointestinal symptoms, especially heartburn or dyspepsia. However, the prevalence of endoscopic erosive esophagitis (EE) and associated risk factors after transplantation are unknown. The aim of this study was to determine whether there was a high incidence of endoscopic findings of EE in solid organ transplant recipients.
METHODS: This retrospective case-control study included 256 of 3,152 solid organ transplant recipients who underwent sequential screening upper endoscopic examinations and an equal number of controls.
RESULTS: Forty-four (17.2%) and 16 (6.2%) cases of EE were detected in the solid organ transplant and control groups, respectively (p<0.001). In the multivariate analysis, transplantation was significantly associated with EE (odds ratio [OR], 6.48; 95% confidence interval, 2.74 to 15.35). Factors such as old age (OR, 1.17), the presence of a hiatal hernia (OR, 5.84), an increased duration of immunosuppression (OR, 1.07), and the maintenance administration of mycophenolate mofetil (OR, 4.13) were independently associated with the occurrence of EE in the solid organ transplant recipients.
CONCLUSIONS: A significant increase in the incidence of endoscopically detected EE was observed in solid organ transplant recipients. This increased incidence was associated with the type and duration of the immunosuppressive therapy.

Entities:  

Keywords:  Barrett esophagus; Erosive esophagitis; Gastroesophageal reflux; Mycophenolate mofetil; Transplantation

Year:  2012        PMID: 22844564      PMCID: PMC3404173          DOI: 10.5009/gnl.2012.6.3.349

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  29 in total

Review 1.  Gastrointestinal complications of transplant immunosuppression.

Authors:  J Harold Helderman; Simin Goral
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

2.  Barrett's Esophagus: Diagnosis, Screening, Surveillance, and Controversies.

Authors:  Rajvinder Singh; Krish Ragunath; Janusz Jankowski
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

Review 3.  Gastroesophageal reflux disease is a progressive disease.

Authors:  F Pace; S Pallotta; N Vakil
Journal:  Dig Liver Dis       Date:  2007-03-26       Impact factor: 4.088

4.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

Review 5.  Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.

Authors:  John Dent
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

6.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.

Authors:  Prateek Sharma; John Dent; David Armstrong; Jacques J G H M Bergman; Liebwin Gossner; Yoshio Hoshihara; Janusz A Jankowski; Ola Junghard; Lars Lundell; Guido N J Tytgat; Michael Vieth
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

Review 7.  Controversies of cardiac glands in the proximal stomach: a critical review.

Authors:  Qin Huang
Journal:  J Gastroenterol Hepatol       Date:  2011-03       Impact factor: 4.029

Review 8.  Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies.

Authors:  Suphamai Bunnapradist; Patrice M Ambühl
Journal:  Clin Transplant       Date:  2008-09-16       Impact factor: 2.863

9.  Meta analysis: Cancer risk in Barrett's oesophagus.

Authors:  T Thomas; K R Abrams; J S De Caestecker; R J Robinson
Journal:  Aliment Pharmacol Ther       Date:  2007-09-26       Impact factor: 8.171

10.  Increased risk of graft failure in kidney transplant recipients after a diagnosis of dyspepsia or gastroesophageal reflux disease.

Authors:  Luca Neri; Lisa A Rocca Rey; Brett W Pinsky; Krista L Lentine; Paolo R Salvalaggio; Gerardo Machnicki; Lisa Willoughby; Thomas E Burroughs; Steven K Takemoto; Mark A Schnitzler
Journal:  Transplantation       Date:  2008-02-15       Impact factor: 4.939

View more
  2 in total

1.  Nausea, Vomiting, and Dyspepsia Following Solid Organ Abdominal Transplant.

Authors:  Simone A Jarrett; Kevin B Lo; Cameron Body; Joyce J Kim; Ziduo Zheng; Suprateek Kundu; Eugene Huang; Arpita Basu; Mary Flynn; Karan A Dietz-Lindo; Nikrad Shahnavaz; Jennifer Christie
Journal:  Cureus       Date:  2022-04-19

2.  Factors leading to dyspepsia in renal transplant recipients.

Authors:  Aisha Nazeer; Ayesha Aslam Rai; Nasir Hassan Luck
Journal:  Pan Afr Med J       Date:  2017-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.